Back
Warby Parker Vs. Perspective Therapeutics Industry Stock Comparison
Sell
18
WRBY
Warby Parker
Last Price:
12.69
Seasonality Move:
-3.7%
Buy
84
CATX
Perspective Therapeutics
Last Price:
1.81
Seasonality Move:
1.64%
Sell
18
Warby Parker (WRBY)
is a Sell
Is Warby Parker a Buy, Sell or Hold?
- The current Warby Parker [WRBY] share price is $12.68. The Score for WRBY is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- WRBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
84
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.81. The Score for CATX is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
WRBY Stock Price Chart
What is Warby Parker's stock price today?
-
The Warby Parker share price today is $12.68
The current trend is relatively stagnant and WRBY is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing slight buying pressure.
WRBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 50.07 | Buy |
| Chaikin Money Flow: | 343392 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 71.56 | Buy |
| Chaikin Money Flow: | 940587 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
WRBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.49 | Buy |
| 20-day SMA: | 12.74 | Sell |
| 50-day SMA: | 12.73 | Sell |
| 200-day SMA: | 12.89 | Sell |
| 8-day EMA: | 12.44 | Buy |
| 20-day EMA: | 12.61 | Buy |
| 50-day EMA: | 12.79 | Sell |
| 200-day EMA: | 13.08 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.68 | Buy |
| 20-day SMA: | 1.58 | Buy |
| 50-day SMA: | 1.32 | Buy |
| 200-day SMA: | 0.65 | Buy |
| 8-day EMA: | 1.69 | Buy |
| 20-day EMA: | 1.58 | Buy |
| 50-day EMA: | 1.34 | Buy |
| 200-day EMA: | 0.82 | Buy |
Warby Parker Earnings Growth & WRBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.04 per share, an increase this year of $0.06 per share, and an increase next year of $0.09 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Warby Parker Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||